Bottom line
How much do FHLC and SWHFX overlap?
76% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 61.8% of FHLC's assets and 60.7% of SWHFX's. They are largely the same portfolio — owning both adds little diversification.
FHLC holds far more positions (337 vs 80), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and SWHFX have in common
| Holding | % of FHLC | % of SWHFX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 13.92% | 13.35% |
| Johnson & Johnson | 8.93% | 6.94% | 6.94% |
| AbbVie Inc | 6.42% | 5.81% | 5.81% |
| UnitedHealth Group Inc | 5.44% | 4.74% | 4.74% |
| Merck & Co Inc | 4.66% | 4.98% | 4.66% |
| Thermo Fisher Scientific Inc | 3.09% | 2.16% | 2.16% |
| Amgen Inc | 3.00% | 2.58% | 2.58% |
| Abbott Laboratories | 2.66% | 1.60% | 1.60% |
| Gilead Sciences Inc | 2.34% | 3.24% | 2.34% |
| Bristol-Myers Squibb Co | 1.93% | 2.44% | 1.93% |
| Danaher Corp | 1.80% | 1.47% | 1.47% |
| Vertex Pharmaceuticals Inc | 1.76% | 1.89% | 1.76% |
| Stryker Corp | 1.62% | 2.11% | 1.62% |
| Medtronic PLC | 1.59% | 2.29% | 1.59% |
| Elevance Health Inc | 1.19% | 1.45% | 1.19% |
| Cigna Group/The | 1.06% | 1.51% | 1.06% |
| Boston Scientific Corp | 1.00% | 1.60% | 1.00% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Pfizer Inc — 2.06%
- CVS Health Corp — 1.92%
- Intuitive Surgical Inc — 1.82%
- McKesson Corp — 1.52%
- Regeneron Pharmaceuticals Inc — 1.15%
- HCA Healthcare Inc — 0.91%
- Cencora Inc — 0.83%
- Cardinal Health Inc — 0.78%
Only in SWHFX
- Novartis AG — 2.92%
- Roche Holding AG — 2.29%
- Gsk Plc — 1.73%
- Incyte Corp — 1.37%
- Ipsen SA — 1.34%
- Sanofi SA — 1.31%
- Becton Dickinson & Co — 1.24%
- Astellas Pharma Inc — 1.19%
Asset mix
| Asset type | FHLC | SWHFX |
|---|---|---|
| Stocks | 99.7% | 99.0% |
| Cash & short-term funds | 0.2% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | FHLC | SWHFX |
|---|---|---|
| US | 96.5% | 78.6% |
| CH | 0.1% | 5.2% |
| IE | 2.2% | 4.5% |
| GB | 0.5% | 3.4% |
| FR | — | 2.6% |
| JP | — | 2.3% |
| NL | 0.1% | 0.7% |
| DK | — | 0.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FHLC and SWHFX overlap?
What stocks do FHLC and SWHFX have in common?
Should I own both FHLC and SWHFX?
Which holds more stocks, FHLC or SWHFX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.